http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1113354-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b97cadfe3493436619037687ef7fcb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
filingDate 2012-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d15c285cc14d1c7caf982c8aa38fa71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8fc95020a927b920c7ecf273eb30a8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b80b56326b1264230ffc877ea81b3b92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfaf84c85368cd85dc29e23be2ad2c0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99a3b7c9c6cf23f65986bacd4b3dd50a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b62a199e42e2ec526698e0ba31086d81
publicationDate 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1113354-T1
titleOfInvention PHOSPHORYLASES AND NUCLEOZIDE NUCLEARIDE INHIBITIONS
abstract The present invention is for compounds of the general formula (purine nucleoside phosphorylates), purine phosphorylase, and 5'-methylthioindustrial phosphate. ). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoan infections and T-cell mediated disease and pharmaceutical compositions containing the compounds.
priorityDate 2005-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813

Total number of triples: 37.